Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples